pGB-Co-Cterm
(Plasmid
#180208)
-
PurposeExpresses GAL4 fusion of Capsaspora NF-kB C-terminal sequences in yeast
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 180208 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGBT9
- Backbone size w/o insert (bp) 5524
- Total vector size (bp) 7600
-
Vector typeYeast Expression
-
Selectable markersTRP1
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCo-RHD
-
Alt nameCapsaspora NF-kB C-terminal Domain Sequences
-
SpeciesCapsaspora owczarzaki
-
Insert Size (bp)2046
-
Mutationaa 542-1224
- Promoter AdhI
-
Tag
/ Fusion Protein
- GAL4 (1-147) fusion (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site SalI (destroyed during cloning)
- 5′ sequencing primer GAL4 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Codon optimized for human cell expression
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGB-Co-Cterm was a gift from Thomas Gilmore (Addgene plasmid # 180208 ; http://n2t.net/addgene:180208 ; RRID:Addgene_180208) -
For your References section:
Comparison of NF-kappaB from the protists Capsaspora owczarzaki and Acanthoeca spectabilis reveals extensive evolutionary diversification of this transcription factor. Williams LM, Sridhar S, Samaroo J, Peart J, Adindu EK, Addanki A, DiRusso CJ, Aguirre Carrion PJ, Rodriguez-Sastre N, Siggers T, Gilmore TD. Commun Biol. 2021 Dec 16;4(1):1404. doi: 10.1038/s42003-021-02924-2. 10.1038/s42003-021-02924-2 PubMed 34916615